Search results
Results from the Tech24 Deals Content Network
Henri Nestlé (1814–1890), a German-born Swiss confectioner, was the founder of Nestlé and one of the main creators of condensed milk. Nestlé's origin dates back to the 1860s when two separate Swiss enterprises were founded that would later form Nestlé. In the following decades, the two competing enterprises expanded their businesses ...
As shareholder. Nestlé owns 23.29% of L'Oréal, the world's largest cosmetics and beauty company, whose brands include Garnier, Maybelline, Lancôme and Urban Decay. Nestlé owned 100% of Alcon in 1978. In 2002 Nestlé sold 23.2% of its Alcon shares on the New York Stock Exchange.
Nestlé-Wyeth Nutrition (formerly owned by Pfizer after the acquisition of Wyeth in 2009) provides food products to meet the needs of infants, young children and adults. Through scientific research, they claim to help nourish children when breastfeeding is not an option. Wyeth Nutrition started in 1915 when Henry Grestberger manufactured the ...
June 6, 2024 at 7:03 AM. (Reuters) -Nestle Health Science will buy the rights to Seres Therapeutics' Vowst, the companies said on Thursday, gaining access to the first ever pill alternative to ...
This is a substantial exit for investors of Munich-based Yfood, which was founded in Munich in 2017 and had only raised $22.6 million in outside backing (including $16 million in 2020).. The deal ...
Nestlé USA just announced that it has acquired Freshly for $1.5 billion — $950 million plus potential earnouts of up to $550 million based on future growth. Founded in 2015, Freshly is a New ...
In early 2013, Pamlab was purchased by Nestlé Health Science. In December 2016, Pamlab was purchased by Alfasigma Group of Bologna, Italy. Legal actions. Alfasigma USA, Inc. was sued by ExeGi Pharma LLC and the Italian inventor of probiotic VSL#3, Claudio De Simone, for making false advertising claims and ownership rights to VSL#3.
In 2014, Nestlé bought back all the shares from L'Oréal, thus creating a new unit of Nestlé group called Nestle Skin Health. The transaction had a value of €3.1 billion (US$4.23 billion) and was paid for by Nestlé with 21.2 million L'Oréal shares. L'Oréal paid €3.4 billion (US$4.63 billion) for the remaining 27.3 million shares.